期刊文献+

射频消融治疗肝脏肿瘤的临床研究 被引量:4

Clinical reasearch on radiofrequency ablation therapy for liver cancer
原文传递
导出
摘要 目的 探讨运用冷循环射频消融技术治疗肝脏肿瘤的效果及其临床应用价值。方法 应用美国RF2000型冷循环射频治疗仪,在局部麻醉或静脉麻醉下将电极针经皮穿刺入瘤体内损毁肿瘤组织,或在开腹直视下行肝穿刺进入瘤体损毁肿瘤组织。对于肿瘤直径较大(〉8cm)或是肿瘤数量较多(〉3个)的患者采用射频治疗和超声聚焦刀、肝动脉栓塞化疗联合的方式进行治疗。用上述方法对2001年11月~2006年6月的347例肝脏肿瘤患者进行了治疗。结果 347例病人中肿瘤单发直径小于或等于3cm者24例,肿瘤完全性毁损。肿瘤单发直径大于3cm小于8cm者89例部分肿瘤完全性损毁。肿瘤多发或单发直径大于8cm者234例,经多点多次联合治疗后仍有肿瘤残余。治疗前甲胎蛋白(alpha,fetop rotcin,AFP)大于或等于400μg/L者261例。术后复查,大部分患者AFP出现不同程度下降。治疗后CT显示治疗区域肿瘤缩小液化坏死或强化减弱。结论 冷循环射频消融是一种创伤小、容易耐受、时间短、安全方便的治疗肝脏肿瘤确实有效的方法。 Objective To explore the clinical effects and value of radiofrequency ablation in treating liver cancer. Methods Use the RF2000 style cool radiofreqeuncy ablation treatment system. Insert the neddle percutaneously to destroy the tumor after local or vein anesthesia or insert the neddle directly during operation. A total of 347 patients were treated this way from Nov. 2001 to Jun, 2006. Results Only 24 patients with single tumor whose diameters were below 3 cm were fully destoryed. Eighty-seven patients with single tumor whose diameters between 3 cm to 8 cm were partly destroyed. Those who have more than one tumor and whose diameters were over 8 cm accepted multi-point treatment with several times and combination treatments, but the tumors were still partly alive. There were 261 patients whose AFP 〉 ≥400 μg/L before traetment, the post-operation test showed that AFP in some of them declined obviously . CT showed that the tumor manifested diminution or liquefaction and the contrast of the therapeutic areas were weakened. Conclusion Radiofrequency ablation is an effective way for hepatocarcinoma treatment. It is invasive, safe, well torlernt, and convenient.
作者 游蓁 李宁
出处 《国际外科学杂志》 2007年第2期90-93,共4页 International Journal of Surgery
关键词 射频消融 肝癌 临床研究 肝穿刺 radiofrequency ablation liver cancer
  • 相关文献

参考文献4

二级参考文献41

  • 1Geschwind JF. Chemoembolization for hepatocellular carcinoma: Where does the truth lie? [J]. J Vasc Interv Radiol, 2002,13(10) :991-994.
  • 2Boucher E, Corbinais S, Brissot P, et al. Treatment of hepatocellular carcinoma with systemic chemotherapy combining epirubicin, cisplatinum and infusional 5-fluorouracil[J]. Cancer Chemother Pharmacol, 2002,50 (4): 305 -308.
  • 3Curley SA. New approaches to the treatment of hepatic malignancies. Radiofrequency ablation of malignant liver tumors [J]. Ann Surg Oncol, 2003,10(4):338-347.
  • 4Buscarini L, Buscarini E, Di Stasi M, et al. Percutanenous radiofrequency ablation of small hepatocellular carcinoma:long-term results[J].Eur Radiol,2001,11(6):914-921.
  • 5Chen MH, Yang W, Yan K, et al. Large liver tumors:protocol for radiofrequency ablation and its clinical application in 110 patients-mathematic model, overlapping mode, and electrode placement process [ J ]. Radiology, 2004,232 ( 1 ):260-271.
  • 6Poon RTP, Fan ST, Yu WC, et al. A prospective longitudinal study of quality of life after resection .of hepatocellular carcinoma [J]. Arch Surg, 2001,136(6) :693-699.
  • 7Acunas B, Rozanes I. Hepatocellular carcinoma: treatment with transcatheter arterial chemoembolization [J]. Eur J Radiol, 1999,32( 1 ): 86-89.
  • 8Goldberg SN, Ahmed M. Minimally invasive image-guided therapies for hepatocellular carcinoma [J ]. J Clin Gastroenterol,2002,35 (Suppl 2): S115-S129.
  • 9Helton WS. Minimizing complications with radiofrequency ablation for liver cancer:the importance of properly controlled clinical trial and standardized reporting [J]. Ann Surg, 2004,239 (4): 459-463.
  • 10Curley SA, Izzo F, Ellis LM, et al. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis [J].Ann Surg Oncol, 2000,232(3) :381-391.

共引文献44

同被引文献26

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部